Philips Lumify Ultrasound FDA Safety Alert: What to Know

The Philips Lumify ultrasound FDA safety alert published on 9 October 2026 concerns a handheld ultrasound system that clinicians use at the bedside, in ambulances and in places far from a hospital. The US Food and Drug Administration said that, as of 29 September, Philips had reported four deaths and eight serious injuries associated with two problems in the Lumify system, and it classed the matter as a potentially high-risk device issue.

This is an early alert, not a recall classification. Below is a plain-language account of what can go wrong, which software versions are named, what users have been told to do, and what remains unexplained.

Philips Lumify ultrasound FDA safety alert: the short version

• Reported harm: four deaths and eight serious injuries as of 29 September 2026. The figures are from Philips, and the alert does not say how each case was linked to the issue.
• Problem one: the Lumify app can fail to recognise a transducer that was already registered, and ask the user to register again with no warning.
• Problem two: the USB cable between the transducer and the phone or tablet can disconnect or become unstable during a scan.
• Who is most exposed: pre-hospital and field users, where Wi-Fi or mobile signal is limited.
• Fix status: a software update for the registration problem is being developed. The cause of the USB problem is still under investigation.

What goes wrong with the Lumify registration prompt

The Lumify system is made of three parts: a transducer, the Lumify app and a compatible Android or iOS device. According to the FDA, a software issue can make the app lose track of a transducer that was registered earlier. The app then asks for registration again, and until that is done the system cannot scan. Registration needs Wi-Fi or a mobile data connection.

In a hospital with reliable coverage, that may mean a short delay. In an ambulance, an aircraft or a field setting, it can mean no scan at all at the moment one is needed. Philips told the FDA of reports of re-registration events that prevented scanning and delayed patient care in areas without coverage. In the agency’s view, a scanner that will not start matters more here than it would on a hospital cart, since clinicians reach for Lumify to make quick bedside decisions and to sort unstable patients, often far from specialist help.

The second Philips Lumify fault: the USB connection

Separately, the physical link between the transducer and the phone or tablet may drop or become unstable during use. A Philips spokesperson described this as a connection problem, and the company is still working on a solution. Whether the unstable connection played any part in the reported injuries and deaths was not stated.

Which software versions does the Philips Lumify ultrasound FDA safety alert name?

The FDA lists the following app versions as affected:

• iOS: 2.X, 5.0, 5.1.2 and 5.1.3.
• Android: 1.X, 3.X, 4.X, 5.1 and 5.1.1.

The alert does not give a number of units or users affected, and press accounts of Philips’s customer letter describe the instructions as covering all Lumify diagnostic ultrasound systems.

What users have been told to do after the Philips Lumify ultrasound FDA safety alert

• Use Lumify only where Wi-Fi or mobile signal is readily available, unless a backup ultrasound device is immediately at hand.
• Always keep backup ultrasound devices or other imaging methods available for patient care.
• Share Philips’s customer letter, dated 24 September 2026, with everyone who uses the device.
• Post the Philips notice near the affected units.

Philips says it is updating its instructions for use, has set up a dedicated taskforce to support customers, and will send follow-up instructions when the software update is ready. US customers can call the Philips Ultrasound Customer Care Solutions Center on 800-722-9377. Problems can also be reported to the FDA through MedWatch.

Why the Philips Lumify ultrasound FDA safety alert matters for point-of-care ultrasound

Handheld ultrasound has spread because it is small and quick, and bodies such as the American College of Emergency Physicians have long promoted point-of-care use in emergency medicine. The same design that makes it portable also ties it to consumer phones, apps and online services. The Philips Lumify ultrasound FDA safety alert shows the weak point: a device that depends on a network check or a loose cable is only as dependable as its worst-connected location. In our assessment, buyers of any app-based clinical device should ask what happens when the connection is gone and whether a safe offline mode exists.

What the Philips Lumify ultrasound FDA safety alert does not tell us

• The root cause of either problem.
• When the software update will be released and which version will contain it.
• How many devices are in use, and how many were affected.
• Whether the deaths and injuries have been independently confirmed as caused by the device problems. The numbers are reported by Philips.
• Whether the issue is confined to the US.
• A formal recall classification. The alert does not assign one.

For related reading on Philips and device safety, see our reports on the Philips sleep apnea device recall and court outcome, the Trace Medical acquisition of the CPAP hygiene maker LiViliti and the Siemens Healthineers Accela imaging launch, or browse more medical device news. The FDA’s full early alert is on its website and the agency says it will update the page as significant new information becomes available.

Frequently asked questions

What is the Philips Lumify ultrasound FDA safety alert?

An FDA early alert, issued 9 October 2026, about registration and USB connection problems in the Lumify ultrasound system, with four deaths and eight serious injuries reported by Philips.

Is the Philips Lumify ultrasound FDA safety alert a recall?

Not formally. The FDA calls it an early alert about a potentially high-risk issue and has not given a recall classification.

What should clinicians do after the Philips Lumify ultrasound FDA safety alert?

Use the system only where there is reliable signal, or with a backup ultrasound device on hand, and keep other imaging available.

Is a fix available after the Philips Lumify ultrasound FDA safety alert?

Not yet for the registration issue. Philips is developing a software update. The USB cause is still being investigated.

Who should report problems?

Users can call Philips customer care or report to the FDA through MedWatch.

How we reported this: we relied on the FDA early alert of 9 October 2026 and trade coverage of Philips’s customer letter. Figures on deaths and injuries are reported by Philips. Last updated: 13 October 2026. This article is news reporting and not medical advice.